+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Effect of NMDA and Non-NMDA Receptor Antagonists on Pulsatile Luteinizing Hormone Secretion in the Adult Male Rat

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          To determine the physiological role of excitatory amino acids (EAAs) in the pulsatile secretion of LH and FSH in the adult male rat, specific antagonists for N-methyl- D-aspartic acid (NMDA) receptors [2-amino-5-phosphono-pen-tanoic acid (AP-5, 10 µg)] and quisqualate/kainate (non-NMDA) receptors [6,7-dinitroquinoxaline-2,3-dione (DNQX; 30 n M)] were administered through intracerebroventricular injection to orchiectomized adult rats. Blood samples were collected from indwelling jugular catheters at 10-min intervals for plasma LH and FSH determinations. The results revealed that administration of a single central injection of AP-5 significantly suppressed LH and FSH mean levels, trough levels and pulse amplitude but not pulse frequency. The non-NMDA receptor antagonist DNQX had no effect on any parameter of LH or FSH secretion after a single central injection. In a second set of experiments, three central injections of the EAA antagonists at 0, 20 and 40 min were utilized in order to give a more prolonged block of the EAA receptors and the effect on pulsatile LH secretion was determined. Regardless of the three injections, AP-5 still did not significantly alter LH pulse frequency. However, the prolonged treatment with DNQX now significantly suppressed mean and trough LH levels as well as LH pulse amplitude with no effect observed on LH pulse frequency. Taken as a whole, the present studies suggest that EAAs are involved in enhancing gonadotropin pulsatility in the male rat and that the effect is exerted primarily on pulse amplitude rather than pulse frequency.

          Related collections

          Author and article information

          S. Karger AG
          09 April 2008
          : 61
          : 3
          : 226-234
          Department of Physiology and Endocrinology, Medical College of Georgia, Augusta, Ga., USA
          126844 Neuroendocrinology 1995;61:226–234
          © 1995 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 9
          Neuroendocrine Effects of Excitatory Amino Acids


          Comment on this article